CIP2A and head and neck squamous cell carcinoma: Using this exceptionally representative PV-TMA material, we analyzed the prognostication capability of multiple biomarkers—p53, EGFR, p16, CIP2A, MET, Oct4, and NDFIP1—previously shown to function as prognostic markers in HNSCC (Fig. 3).